| 000 | 01567 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516031211.0 | ||
| 264 | 0 | _c20120914 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a1573-7217 | ||
| 024 | 7 |
_a10.1007/s10549-011-1451-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Munck, L | |
| 245 | 0 | 0 |
_aImplementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands. _h[electronic resource] |
| 260 |
_bBreast cancer research and treatment _cAug 2011 |
||
| 300 |
_a229-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNetherlands |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTrastuzumab |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aSchaapveld, M | |
| 700 | 1 | _aSiesling, S | |
| 700 | 1 | _aWesseling, J | |
| 700 | 1 | _aVoogd, A C | |
| 700 | 1 | _aTjan-Heijnen, V C G | |
| 700 | 1 | _aOtter, R | |
| 700 | 1 | _aWillemse, P H B | |
| 773 | 0 |
_tBreast cancer research and treatment _gvol. 129 _gno. 1 _gp. 229-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10549-011-1451-0 _zAvailable from publisher's website |
| 999 |
_c20701756 _d20701756 |
||